Discover 3,590 paid clinical trials in Pasadena, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,590
Characterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
for
Acute Myeloid Leukemia
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT03921047
Recruiting
Blue Light Cystoscopy With Cysview® Registry
for
Bladder Cancer
Location: Los Angeles CA, Palo Alto CA, San Francisco CA,
Sponsor: Photocure
Sex: All
Age: 18+
Code: NCT02660645
Recruiting
Norris ORIEN Total Cancer Care
for
Cancer Risk, Malignant Neoplasm
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT02970045
Recruiting
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
for
Metastatic Dedifferentiated Liposarcoma,
Location: Los Angeles CA, Aurora CO, Houston TX, St Louis MO,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05711615
Phase 1, Recruiting
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: Los Angeles CA, Orange CA, San Francisco CA, Gilbert AZ,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06001788
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses
for
Breast Carcinoma
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: Female
Age: 18+
Code: NCT06171607
Phase 1, Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Los Angeles CA, La Jolla CA, West Valley City UT,
Sponsor: Iambic Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06253871
Phase 1, Recruiting
Core Biopsies for Establishing a Breast Tumor Tissue Repository
for
Breast Cancer
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT02250352
Recruiting
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer
for
Metastatic Nasopharyngeal Carcinoma,
Location: Los Angeles CA, Newport Beach CA, Fresno CA, Modesto CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06029270
Phase 2, Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Location: Los Angeles CA, La Jolla CA, Portland OR, Denver CO,
Sponsor: PMV Pharmaceuticals, Inc
Sex: All
Age: 12+
Code: NCT04585750
Phase 1, Phase 2, Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
for
Metastatic Renal Cell Carcinoma,
Location: Los Angeles CA, Beverly Hills CA, Orange CA, Irvine CA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT05327686
Phase 2, Recruiting
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
for
Castration Levels of Testosterone,
Location: Los Angeles CA, Duarte CA, Long Beach CA,
Sponsor: SWOG Cancer Research Network
Sex: Male
Age: 18+
Code: NCT03678025
Phase 3, Recruiting
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
for
Locally Advanced Lung Non-Small Cell Carcinoma,
Location: Los Angeles CA, Bakersfield CA, Kingman AZ, Modesto CA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT05624996
Phase 3, Recruiting
A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
for
GIST
Location: Los Angeles CA, Portland OR, St Louis MO,
Sponsor: Deciphera Pharmaceuticals, LLC
Sex: All
Age: 18+
Code: NCT05957367
Phase 1, Phase 2, Recruiting
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors